icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Safety of Sofosbuvir-Based Regimens for the Treatment of Chronic HCV Infection in Patients With Mild or Moderate Renal Impairment
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Francois Durand,1 Stephen Pianko,2 Liyun Ni,3 Shampa De-Oertel,3 John McNally,3 Diana M. Brainard,3 John G. McHutchison,3 Eugene Schiff,4 Massimo Colombo5 1H˘pital Beaujon, University Paris Diderot, Clichy, France; 2Monash Health, Clayton, Victoria, Australia; 3Gilead Sciences, Inc., Foster City, CA; 4Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, FL; 5Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

HCV1

HCV2

HCV3